1owd

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:1owd.gif|left|200px]]
[[Image:1owd.gif|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 1owd |SIZE=350|CAPTION= <scene name='initialview01'>1owd</scene>, resolution 2.32&Aring;
+
The line below this paragraph, containing "STRUCTURE_1owd", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=497:6-[AMINO(IMINO)METHYL]-N-[(4R)-4-ETHYL-1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL]-2-NAPHTHAMIDE'>497</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/U-plasminogen_activator U-plasminogen activator], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.73 3.4.21.73] </span>
+
or leave the SCENE parameter empty for the default display.
-
|GENE= PLAU ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
+
-->
-
|DOMAIN=
+
{{STRUCTURE_1owd| PDB=1owd | SCENE= }}
-
|RELATEDENTRY=[[1fv9|1FV9]], [[1owe|1OWE]], [[1owh|1OWH]], [[1owi|1OWI]], [[1owj|1OWJ]], [[1owk|1OWK]]
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1owd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1owd OCA], [http://www.ebi.ac.uk/pdbsum/1owd PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1owd RCSB]</span>
+
-
}}
+
'''Substituted 2-Naphthamidine inhibitors of urokinase'''
'''Substituted 2-Naphthamidine inhibitors of urokinase'''
Line 40: Line 37:
[[Category: Wendt, M D.]]
[[Category: Wendt, M D.]]
[[Category: Zhao, X.]]
[[Category: Zhao, X.]]
-
[[Category: egf-like domain]]
+
[[Category: Egf-like domain]]
-
[[Category: glycoprotein]]
+
[[Category: Glycoprotein]]
-
[[Category: hydrolase]]
+
[[Category: Hydrolase]]
-
[[Category: kringle]]
+
[[Category: Kringle]]
-
[[Category: plasminogen activation]]
+
[[Category: Plasminogen activation]]
-
[[Category: serine protease]]
+
[[Category: Serine protease]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 04:21:21 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 22:51:19 2008''
+

Revision as of 01:21, 3 May 2008

Template:STRUCTURE 1owd

Substituted 2-Naphthamidine inhibitors of urokinase


Contents

Overview

The preparation and assessment of biological activity of 6-substituted 2-naphthamidine inhibitors of the serine protease urokinase plasminogen activator (uPA, or urokinase) is described. 2-Naphthamidine was chosen as a starting point based on synthetic considerations and on modeling of substituent vectors. Phenyl amides at the 6-position were found to improve binding; replacement of the amide with other two-atom linkers proved ineffective. The phenyl group itself is situated near the S1' subsite; substitutions off of the phenyl group accessed S1' and other distant binding regions. Three new points of interaction were defined and explored through ring substitution. A solvent-exposed salt bridge with the Asp60A carboxylate was formed using a 4-alkylamino group, improving affinity to K(i) = 40 nM. Inhibitors also accessed two hydrophobic regions. One interaction is characterized by a tight hydrophobic fit made with a small dimple largely defined by His57 and His99; a weaker, less specific interaction involves alkyl groups reaching into the broad prime-side protein binding region near Val41 and the Cys42-Cys58 disulfide, displacing water molecules and leading to small gains in activity. Many inhibitors accessed two of these three regions. Affinities range as low as K(i) = 6 nM, and many compounds had K(i) < 100 nM, while moderate to excellent selectivity was gained versus four of five members of a panel of relevant serine proteases. Also, some selectivity against trypsin was generated via the interaction with Asp60A. X-ray structures of many of these compounds were used to inform our inhibitor design and to increase our understanding of key interactions. In combination with our exploration of 8-substitution patterns, we have identified a number of novel binding interactions for uPA inhibitors.

Disease

Known disease associated with this structure: Alzheimer disease, late-onset, susceptibility to OMIM:[191840]

About this Structure

1OWD is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution., Wendt MD, Rockway TW, Geyer A, McClellan W, Weitzberg M, Zhao X, Mantei R, Nienaber VL, Stewart K, Klinghofer V, Giranda VL, J Med Chem. 2004 Jan 15;47(2):303-24. PMID:14711304 Page seeded by OCA on Sat May 3 04:21:21 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools